Acquisition of Cardiovascular Medications
About This Opportunity
TranslatedThis tender pertains to the acquisition of medications specifically for the cardiovascular system. The objective is to procure high-quality pharmaceutical products that are essential for the treatment and management of cardiovascular diseases. The tender is aimed at suppliers who can provide a range of medications that meet the necessary regulatory standards and quality assurance protocols. Key requirements include the ability to deliver medications in a timely manner, adherence to specified dosage forms, and compliance with safety and efficacy standards. Interested bidders must demonstrate their capacity to supply the required quantities and maintain consistent supply chains. The procurement process is expected to enhance the availability of essential cardiovascular medications in healthcare facilities, thereby improving patient outcomes. This tender is particularly relevant to the healthcare sector and will be executed in accordance with public procurement regulations. Suppliers are encouraged to submit their proposals, detailing their qualifications, experience, and pricing structures. The location of the procurement will be specified in the tender documents, and potential bidders should ensure they have the necessary certifications and licenses to operate within the jurisdiction. Overall, this tender represents a significant opportunity for pharmaceutical companies to contribute to public health initiatives focused on cardiovascular care.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 574.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from PortugueseThe tender titled "Aquisição de Medicamentos do Aparelho Cardiovascular" pertains to the procurement of cardiovascular medications in Portugal. This initiative is part of the government's commitment to enhancing healthcare services and ensuring the availability of essential medications for the treatment of cardiovascular diseases, which are a leading cause of morbidity and mortality globally.
The contracting authority overseeing this tender is aligned with the principles of public health and aims to secure high-quality pharmaceuticals that meet rigorous safety and efficacy standards. Suppliers are invited to submit their proposals for the provision of various cardiovascular drugs, which may encompass a range of therapeutic classes, including antihypertensives, anticoagulants, and lipid-lowering agents.
Typical requirements for this type of tender include the demonstration of compliance with national and European pharmaceutical regulations, evidence of the capability to supply medications in accordance with specified quantities and delivery timelines, and the provision of documentation related to product quality and safety. Additionally, bidders may be required to outline their experience in the pharmaceutical sector, particularly in supplying public health institutions.
Interested parties should ensure they are familiar with the regulatory framework governing pharmaceutical procurement in Portugal, as well as any specific protocols established by the contracting authority. This tender represents an important opportunity for pharmaceutical companies to contribute to public health initiatives and support the management of cardiovascular conditions within the Portuguese healthcare system.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 10, 2026. Last refreshed 77 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Alto Alentejo E.P.E
Unidade Local de Saúde do Alto Alentejo E.P.E has issued 626 procurement notices on BidsFactory, including 0 currently open and 625 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: August 3, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to SPCARE, Especialidades Farmacêuticas, Ldª. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Alto Alentejo E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €574. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.